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a b s t r a c t
Geminin is a nucleoprotein that can directly bind chromatin regulatory complexes to modulate gene
expression during development. Geminin knockout mouse embryos are preimplantation lethal by the
32-cell stage, precluding in vivo study of Geminin's role in neural development. Therefore, here we used
a conditional Geminin allele in combination with several Cre-driver lines to deﬁne an essential role for
Geminin during mammalian neural tube (NT) formation and patterning. Geminin was required in the NT
within a critical developmental time window (embryonic day 8.5–10.5), when NT patterning and closure
occurs. Geminin excision at these stages resulted in strongly diminished expression of genes that mark
and promote dorsal NT identities and decreased differentiation of ventral motor neurons, resulting in
completely penetrant NT defects, while excision after embryonic day 10.5 did not result in NT defects.
When Geminin was deleted speciﬁcally in the spinal NT, both NT defects and axial skeleton defects were
observed, but neither defect occurred when Geminin was excised in paraxial mesenchyme, indicating a
tissue autonomous requirement for Geminin in developing neuroectoderm. Despite a potential role for
Geminin in cell cycle control, we found no evidence of proliferation defects or altered apoptosis.
Comparisons of gene expression in the NT of Geminin mutant versus wild-type siblings at embryonic day
10.5 revealed decreased expression of key regulators of neurogenesis, including neurogenic bHLH
transcription factors and dorsal interneuron progenitor markers. Together, these data demonstrate a
requirement for Geminin for NT patterning and neuronal differentiation during mammalian neurulation
in vivo.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Neural tube defects (NTDs) are a common birth defect, occurring
in approximately 1:1000 human births, and typically present as
spina biﬁda or anencephaly in humans (Boulet et al., 2008). While
folic acid supplementation has reduced the frequency of neural tube
defects in clinical studies and myo-inositol can prevent some folate-
resistant NTDs in mice, they remain a signiﬁcant human health
concern (Greene and Copp, 1997; MRC Vitamin Study Research
Group, 1991). The etiology of NTDs is complex involving both genetic
susceptibilities and environmental factors and, as a result, the
underlying mechanisms are not well understood. Over 200 genes
have been found to cause or contribute to increased risk of NTDs in
mouse or human (Harris and Juriloff, 2010). The large number of
genetic defects that cause NTDs is due to the many steps that can be
disrupted during the intricate process of neurulation.
Neurulation in mammals originates with speciﬁcation of a ﬂat
neuroepithelium that rises at the lateral edges to form the neural
tube. The dorsal tips of the neural tube extend ﬁlopodia and “fuse”
through a process involving epithelial cell remodeling. Fusion of the
neural tube initiates at the level of the 3rd somite (the future cervical/
hindbrain boundary) at embryonic day 8.5 (E8.5) and proceeds both
cranially and caudally (Copp et al., 2003; Greene and Copp, 2009).
Neural tube fusion in the head is completed by E9.5, while spinal
neural tube fusion is completed by E10.5 (Copp et al., 2003). Failure of
neural plate elevation, apposition of neural folds, or fusion results in
NTDs. Another critical step of neural tube formation that can cause
NTDs when perturbed is speciﬁcation and differentiation of cells in
the neural tube (Copp and Greene, 2010).
Speciﬁcation and differentiation of neural progenitors is regu-
lated by Shh signaling from the ventral notochord and ﬂoor plate
(Chiang et al., 1996; Martí et al., 1995; Roelink et al., 1995) and
Bmp/Wnt signaling from the dorsal roof plate (Lee et al., 2000;
Liem et al., 1997, 1995). Dose-dependent signaling induces neuro-
genic transcription factors that specify distinct neural progenitors
(dorsal progenitor domains 1–6, ventral progenitor domains 0–3,
and motor neuron progenitors) (Briscoe et al., 2000; Ericson et al.,
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1997; Lee and Jessell, 1999). Speciﬁcation of progenitors and
subsequent differentiation occurs in ventral regions ﬁrst, and then
proceeds dorsally such that ventral neurons are produced prior to
dorsal neurons at a given rostral–caudal position. In addition,
there is a rostral to caudal progression of differentiation within the
neural tube, such that rostral cells at a given dorsal–ventral
position differentiate prior to cells at the same dorsal–ventral
level that are located more caudally.
Both transcription factors and activities that modulate chro-
matin structure are required for neural tube closure, but the
downstream pathways they control are largely unknown (Copp
and Greene, 2010; Harris and Juriloff, 2007). Mutations in several
epigenetic regulatory proteins that control histone modiﬁcation
states or remodel nucleosomes to alter gene expression are
implicated in NTDs. For example, NTDs result from mutations in
the histone acetyl transferases (HATs) Gcn5 (Bu et al., 2007; Lin et
al., 2008), Ep300 (Yao et al., 1998), and CBP (Oike et al., 1999).
Similar phenotypes are seen with proteins that interact with these
HATs including Cited2 (Bamforth et al., 2001; Barbera et al., 2002)
and Tfap2a (Schorle et al., 1996; Zhang et al., 1996). Mutation of
several core components of the SWI/SNF chromatin remodeling
complex also results in NTDs (Bultman et al., 2000; Harmacek et
al., 2014) as does mutation of a chromatin remodeling complex-
associated protein, Cecr2 (Banting et al., 2005; Davidson et al.,
2007). In addition, folic acid, which prevents some NTDs, can exert
downstream effects at the epigenetic level by altering histone H3
lysine27 (H3K27) methylation status at promoters of critical neural
transcription factors (Hes1 and Ngn2) (Ichi et al., 2010). Together,
these defects demonstrate that dysregulation of epigenetic con-
trols can result in NTDs, although mechanisms through which this
occurs remain poorly understood.
Another potential regulator of embryogenesis is Geminin,
a small nuclear protein initially identiﬁed in both a screen for
proteins degraded during mitosis and a screen for genes that
expanded the neural plate in early Xenopus embryos (Kroll et al.,
1998; McGarry and Kirschner, 1998). Geminin has multiple func-
tions through interaction with chromatin binding proteins includ-
ing preventing re-replication of DNA during the cell cycle through
inhibitory binding to the pre-replication protein Cdt1 as well as
controlling gene expression by binding to Brg1, the catalytic
component of the SWI/SNF chromatin remodeling complex, and
by functional cooperation with Polycomb repressive complexes to
affect transcriptional activity (Lim et al., 2011; Luo et al., 2004;
Ohtsubo et al., 2008; Wohlschlegel et al., 2000). In addition,
Geminin can indirectly promote histone acetylation at neural
genes during neural fate acquisition of embryonic stem cells
in vitro, although the speciﬁc mechanism underlying this activity
is not understood (Yellajoshyula et al., 2011). While Geminin can
expand the neural plate in the developing amphibian embryo, its
role during mammalian neurogenesis in vivo has not been
investigated.
Homozygous Geminin null embryos are preimplantation lethal by
the 32-cell stage, in part due to conversion of Oct4-positive inner cell
mass cells to Cdx2-positive trophoblast giant cells (Gonzalez et al.,
2006), precluding analysis of later in vivo requirements for Geminin
during mammalian development. Conditional excision of Geminin
was previously investigated in the context of neural stem cell
maintenance and differentiation (Schultz et al., 2011; Spella et al.,
2011), but has not been investigated during the initial formation and
patterning of the mammalian neural tube. A recent study used a
shRNA knockdown approach to reduce Geminin during gastrulation
and identiﬁed a role for Geminin during gastrulation (Emmett and
O’Shea, 2012). However, these embryos failed to survive to stages
needed to determine whether Geminin plays a putative role in neural
plate formation and patterning. Therefore, here we used multiple Cre
lines in combination with a conditional Geminin allele to deﬁne
requirements for Geminin during mammalian neural tube formation
and patterning.
Materials and methods
Animal husbandry
Animal studies were conducted under protocols approved by
the Washington University Institutional Animal Care and Use
Committee (Protocol #: 20130075). Geminin conditional knockout
mice (CSD24729) were purchased from the Knockout Mouse
Project (KOMP). The targeted Geminin allele contains a splice
acceptor-βgeo-polyA sequence ﬂanked by FRT sites (permitting
excision by FLPe recombinase) inserted into intron 3 and loxP sites
ﬂanking exon 4 (permitting excision of exon 4 by Cre recombi-
nase). Prior to FLPe excision of the splice acceptor-βgeo-polyA
sequence, the targeted allele is predicted to be a null allele of
Geminin. Excision by FLPe recombinase results in a targeted
(ﬂoxed) allele that generates a wild-type mRNA. This ﬂoxed allele
can be converted to a null allele in the presence of Cre, which
excises exon4. Mox2-Cre (003755), Sox2-Cre (008454), Wnt1-Cre
(009107), ACTFLPe (005703) and ROSA26R (003474) mice were
purchased from The Jackson Laboratory. Pax3Pro-Cre (Pax3-Cre)
(Li et al., 2000), Nestin-Cre (Tronche et al., 1999), and Dermo1-Cre
(Šošić et al., 2003) mice were obtained from Drs. Jeffrey Miner,
Naren Ramanan, and David Ornitz respectively. For timed matings,
noon of the day of plug discovery was designated E0.5. Embryos
between E8.5 and E10.5 were staged more speciﬁcally by somite
number (Copp et al., 2000).
Genotyping
DNA was extracted from embryonic membranes or tail tissue
using the HotShot method for 15 min (Truett et al., 2000) and 2 ml
DNA was used for PCR with Phusion polymerase (New England
Biolabs). For Geminin and Cre PCRs, cycling conditions were 98 1C
for 60 s followed by 33 cycles of (98 1C 10 s, 65 1C 10 s, 72 1C 30 s).
Primers for genotyping are in Supplementary Table S1.
Immunohistochemistry (IHC)
Embryos were ﬁxed in 4% paraformaldehyde overnight and
processed to generate 10 mm frozen or 5 mm parafﬁn sections.
Antigen retrieval using citrate buffer (10 mM Sodium citrate pH
6.0) and a pressure cooker for 10 min was used to treat parafﬁn
sections prior to immunostaining. Transverse sections were
stained with 1% toluidine blue to determine anterior–posterior
location using anatomical landmarks including limb buds, the
heart, and the gut. Immunohistochemistry was performed on
transverse sections caudal to the forelimb (E9.5) and between
the forelimb and hindlimb of E10.5, E11.5, and E12.5 embryos
(caudal to the heart and containing gut). Anterior–posterior
matched sections were used for immunohistochemistry analysis
of wild-type and mutant embryos. Antibodies are listed in
Supplementary Table S2. After antibody staining, immunohisto-
chemical sections were counterstained with DAPI (represented in
blue). Whole mount immunohistochemistry using 2H3 neuroﬁla-
ment antibody was performed as previously described (Joyner and
Wall, 2008).
In situ hybridization
Embryos were dissected free from extraembryonic membranes
and ﬁxed in 4% paraformaldehyde overnight at 4 1C. in situ
hybridization using a probe corresponding to the Geminin open
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reading frame was performed as previously described (Wilkinson
and Nieto, 1993).
Image processing
Immunoﬂuorescence imaging was performed on a Zeiss Axio
Imager Z1 at 10 or 20 magniﬁcation. Whole mount images of
embryos at E18.5 were taken using a Zeiss Stereo Discovery V12 and
individual images were stitched together using the Fiji Stitching
plugin software as needed.
qRT-PCR
Embryos were dissected free of membranes and visceral
organs. Dorsal tissue from the ﬁrst to the last full somite was
collected and RNA was extracted (Nucleospin RNAII kit; Clontech).
cDNA was synthesized using random primers and Superscript II
(Invitrogen). Fast Sybr Green Mastermix (Applied Biosystems) was
used for qPCR with gene speciﬁc primers that ampliﬁed across
exon–exon junctions (Supplementary Table S3). qPCR was per-
formed on an ABI Fast 7500 using the cycling conditions 95 1C
2 min, 40 (95 1C 10 s, 60 1C 45 s). Each qPCR was performed in
triplicate, with normalization to Rpl19 expression level.
Skeletal preparations
Embryos were dissected free of membranes, de-skinned, and
ﬁxed for 24 h in 95% ethanol, followed by 24 h in acetone. Embryos
were stained overnight in 70% ethanol/5% acetic acid/0.015% Alcian
Blue/0.005% Alizarin Red. Maceration was done in 1% potassium
hydroxide / 20% glycerol until embryos were clear. After further
clearing in 50% and 80% glycerol, embryos were photographed on
a Zeiss Stereo Discovery V12 microscope.
Folate/inositol supplementation
Folate (Sigma) supplementation was provided via drinking
water at 0.2 mg/L. Myo-inositol (Sigma) was given in drinking
water at 10 mg/mL. Dams were provided folate or myo-inositol
supplemented water ad libitum for at least 3 weeks prior to
mating and supplementation was continued until embryos were
harvested.
Laser capture microdissection
Embryos were dissected and frozen immediately in OCT (Tissue-
Tek). 30 mm frozen sections were generated from somite-matched
mutant (Mox2Cre; Gmnnﬂox/ﬂox) and wild-type (Mox2Cre; Gmnnþ /ﬂox)
sibling embryos, by transverse sectioning through the spinal neural
tube between the forelimb and hindlimb bud regions at E10.5.
Neural tube and surrounding paraxial tissue were isolated sepa-
rately by laser capture microdissection using a Leica LMD7000.
Examples of the regions acquired are shown in Supplementary
Fig. S1. All sections between the levels of the forelimb and hindlimb
were combined and used to prepare RNA from laser captured
material (Arcturus PicoPure RNA Isolation kit; Life Technologies)
and quality was assessed by Agilent 2100 bioanalyzer (Agilent).
cDNA was generated and hybridized to Agilent Mouse 860 K
microarrays by the Genome Technology Access Center (WUSM).
Agilent Feature Extraction software was used to obtain background
subtracted and spatially detrended ProcessedSignal intensities and
features ﬂagged as non-uniform outliers were excluded.
To deﬁne genes with differential expression between wild-type
and mutant tissue, we excluded all probes that were not signiﬁ-
cantly expressed above background in at least one sample for each
experimental pair (wild-type or mutant). We generated fold
change ratios from ProcessedSignal intensities between mutant
and wild-type paired samples. We further considered probesets
where both independent experiments showed a 42-fold change
in the same direction in mutant/wild-type ratio comparisons and
where all probesets corresponding to a single gene showed a
consistent difference between mutant and wild-type samples.
These data were deposited into the Gene Expression Omnibus
(GSE42052).
Results
Geminin deﬁcient embryos generated by Mox2-Cre mediated excision
are present in Mendelian ratios throughout gestation
Geminin (Gmnn) is strongly expressed in the neural tube at
embryonic day 10.5 (E10.5) and continues to be expressed through
E14.5, as detected both by in situ hybridization and immunohis-
tochemistry (Fig. 1A). In transverse sections of the spinal neural
tube, expression is strongest in the proliferating cells of the central
ventricular zone (Fig. 1A), while expression is not seen in the
ventral horns, which contain differentiating neurons. Staining is
also present in some dividing cells of the paraxial mesenchyme.
To investigate the role of Geminin in neuroepithelium, we
obtained Gmnnþ /βgeo mice, a model in which exon 4 is ﬂanked by
loxP sites. We ﬁrst excised the FRT-ﬂanked βgeo cassette by
breeding to constitutive FlpE-expressing mice to generate a ﬂoxed
allele (Fig. 1B). Gmnnﬂox/ﬂox mice are viable, fertile, and phenoty-
pically indistinguishable from wild-type mice. We next bred
Gmnnﬂox/ﬂox female mice to Sox2Cre; Gmnnþ /ﬂox; male mice to
generate a ΔEx4 allele (Fig. 1B). Heterozygous (Gmnnþ /ΔEx4) mice
were crossed and we obtained 13 Gmnnþ /þ and 35 Gmnnþ /ΔEx4
pups, while no GmnnΔEx4/ΔEx4 pups were found at postnatal day 1
(Fisher's Exact test p¼0.001). This was consistent with homozy-
gous deletion of Geminin causing lethality prior to birth, as
expected based on preimplantation lethality of the Geminin null
allele (Gonzalez et al., 2006). In addition, although we could detect
a low level of ΔEx4 transcript in embryos, we could not detect the
predicted carboxyl-terminally truncated protein by Western blot
using an antibody recognizing the amino-terminal region of
Geminin (Fig. S2 A and B). This indicates that the ΔEx4 allele
generated after Cre excision is a null or strong hypomorphic allele
as predicted.
We used the Geminin ﬂoxed allele in combination with Mox2-
Cre, which enables early excision (from E5.5) in the embryonic
epiblast and its derivatives (Tallquist and Soriano, 2000). To lineage
mark Mox2-Cre expressing cells, we generated Mox2Cre;ROSA26R
mice. By day E9.5, most embryonic cells were β-galactosidase-
positive, including cells throughout the neural tube and paraxial
tissues (Fig. 1C). In Mox2Cre; Gmnnﬂox/ﬂox embryos, Geminin is
efﬁciently excised in the spinal neural tube, as indicated by loss of
Geminin immunostaining (Fig. 1D). As Geminin null mice are
preimplantation lethal at approximately E3.5 (Gonzalez et al.,
2006), we initially performed timed matings to determine if mutant
embryos (Mox2Cre; Gmnnﬂox/ﬂox) were obtained at or after gastrula-
tion stages (E7.5) and found the expected Mendelian ratios at this
timepoint (Fig. S2 C). Additionally, mutant embryos were morpho-
logically indistinguishable from wild-type embryos. We subse-
quently analyzed timed matings from E7.5 to E18.5 and found that
mutant embryos were obtained in expected numbers through E18.5
(Fig. S2 C), but were never found alive after birth. We obtained 412
pups (P0) in matings of Gmnnﬂox/ﬂox mice to Mox2Cre; Gmnnþ /ﬂox
mice, but only found 2 stillborn Mox2Cre; Gmnnﬂox/ﬂox pups com-
pared to the expected 103 pups. This indicates that the Mox2Cre;
Gmnnﬂox/ﬂox genotype is lethal in the perinatal period.
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Geminin deﬁcient embryos have spinal neural tube defects
We assessed the phenotype of the Mox2Cre; Gmnnﬂox/ﬂox
(mutant) embryos. Mutant embryos were indistinguishable from
wild-type littermates until E11.5 when they appeared slightly
smaller. At E12.5, mutant embryos were present in Mendelian
ratios, but were smaller and had complete penetrance of spinal
neural tube defects (NTD), often exhibiting a kinked neural tube
(Fig. 2A, arrowhead). While the neural tube is formed and the
neural folds rise to contact each other in mutant embryos, the roof
plate fails to remodel and is substantially thinner than that of
wild-type embryos (Fig. 2B and C). At E14.5, mutant embryos
continue to show kinked neural tubes (Fig. 2D and E, arrowhead).
At E18.5, mutant embryos had complete penetrance of spinal NTDs
(Fig. 2F–K), as well as incomplete penetrance of microphthalmia
(20%) (Fig. 2L and M) and mandible agenesis (o5%) (Fig. 2N and
O). In addition, these embryos were alive, responded to touch, and
had caudal NTDs combined with extensive edema and lack of
muscular tone in the lower extremities. Mutant tails were often
short and curled and were 25% the length of wild-type tails,
consistent with a failure of secondary neurulation (Fig. 2P and Q).
Transverse sections through the affected region of the neural tube
show a disrupted spinal neural tube with a juxtaposition of the
dorsal neural tube and the skin (Fig S3). We further investigated
the phenotype of the mutant embryos at E18.5 by performing
bone and cartilage preparations. While we found the appendicular
skeleton to be normal in mutant embryos, the axial skeleton was
severely affected. Defects ranged from malformed vertebral bodies
and neural arches to loss of ossiﬁed proximal ribs to total loss of all
vertebrae and ribs (Fig. 2R and T). Overall, skeletal malformations
were completely penetrant with only 30% of mutant embryos
having ribs (all ribs were malformed/residual). Vertebral body
malformation was completely penetrant with all mutant embryos
lacking a complete set of vertebral bodies and 20% lacking any
vertebral bodies. Most mutant embryos had some neural arches,
but none had a complete set and the neural arches were often not
symmetric.
Many neural tube defects can be prevented by folic acid or
inositol supplementation prior to and during early pregnancy. We
supplemented the drinking water of dams with folic acid or myo-
inositol to determine if the spinal NTD resulting from Geminin
deﬁciency could be prevented. However, neither folic acid nor
myo-inositol supplementation prevented these NTDs, indicating
either that defects caused by loss of Geminin are unrelated to
pathways sensitive to these molecules or that Geminin acts
downstream of processes requiring folate or myo-inositol (data
not shown).
Alterations in neural tube patterning and differentiation in Geminin
deﬁcient embryos
In some contexts, Geminin contributes to cell cycle control,
preventing re-licensing of DNA origins within S and G2 phase of
the cell cycle by binding the pre-replication protein Cdt1. To
determine if Geminin deﬁciency altered cell proliferation in this
mouse model, we immunostained transverse sections of the E10.5
spinal neural tube with antibodies against Ki67, which marks all
dividing cells, and phosphorylated-histone H3-Ser10 (pH3), which
marks mitotic cells. Neural tubes from mutant embryos and their
wild-type siblings had indistinguishable numbers of Ki67-positive
and pH3-positive cells (Fig. 3A–C). We also assessed whether
Geminin deﬁciency altered the number of cells undergoing
apoptosis, by immunostaining spinal NT sections for activated
Caspase3. There were very few activated Caspase3-positive cells
outside of the dorsal root ganglia in both wild-type and mutant
embryos and we did not detect a difference in apoptotic cell
number between wild-type and mutant embryos (Fig. 3D).
Together, these ﬁndings suggest that cell proliferation and apop-
tosis are not discernibly affected in these Geminin deﬁcient
embryos.
Dorsal–ventral patterning of the neural tube is determined by
graded Shh, Wnt, and Bmp signaling, which establishes the
ordered expression of distinct transcription factors (Jessell, 2000;
Le Dréau and Martí, 2012; Liu and Niswander, 2005; Ribes and
Fig. 1. Geminin expression and excision by Mox2-Cre during embryogenesis. (A) Geminin is predominantly expressed in the neural tube at E10.5 (in situ hybridization (ISH),
left panel) and E14.5 (immunohistochemistry (IHC), center). IHC for Geminin on an E11.5 transverse section through the spinal neural tube demonstrates strong staining in
the ventricular region of the neural tube (right). DAPI counterstain in blue. (B) Schematic of endogenous and conditional Geminin alleles. Exons are black boxes, introns are
lines, red arrowhead indicates loxP sites, and black arrow indicates transcription start site. (C) Mox2-Cre is expressed throughout the E9.5 embryo. Transverse section shows
broad β-galactosidase staining. (D) Geminin IHC shows efﬁcient excision by Mox2-Cre in the spinal neural tube of mutant (Mox2Cre; Gmnnﬂox/ﬂox) embryos by E10.5. Scale
bars¼100 mm.
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Briscoe, 2009; Wilson and Maden, 2005). Dorsal Bmp and Wnt
signaling induces the roof plate and six dorsal interneuron
progenitor cell populations (pd 1–6), while Shh produced by the
notochord and ﬂoor plate is required for the formation of ﬂoor
plate, motor neuron progenitors, and four other ventral neuron
progenitor cell types (pv 0–3) (Alaynick et al., 2011; Briscoe et al.,
2000; Ericson et al., 1997; Lee and Pfaff, 2001). To determine if
Geminin loss affected dorsal–ventral patterning of the spinal
neural tube at E9.5 and E10.5, we performed immunostaining for
markers of dorsal and ventral progenitors and neuronal cell
populations that differentiate from these progenitors. Expression
of Nkx6.1 (which marks ﬂoor plate, v2–3, and motor neuron
progenitors), Olig2 (which marks motor neuron progenitors),
Nkx2.2 (which marks v3 progenitors), and the ﬂoor plate marker
Foxa2 was unchanged in mutant embryos at E9.5, indicating that
initial speciﬁcation of ventral progenitors is not affected in mutant
embryos (Fig. S4). At E10.5, both mutant and wild-type embryos
strongly express Foxa2 (Fig. 3E), suggesting that short-range
responses to Shh to generate the ﬂoor plate are unaffected in the
mutant. Similarly, the roof plate in mutants still expresses Lmx1a,
despite having altered morphology (Fig. 3F). Expression of the
pan-neural progenitor marker Sox1 is unaffected in the mutant
(Fig. 3G), as are markers of ventral progenitor identity: neither
Olig2 expression nor Nkx6.1 is altered in the mutant (Fig. 3H
and I), while Nkx2.2 has a slightly expanded domain (Fig. 3J).
In contrast, markers of differentiated motor neurons, Isl1 and Hb9,
are strongly reduced in mutant embryos, as is expression of Lhx3,
which marks v2 progenitors and motor neuron progenitors
(Fig. 3K–M). The neuronal marker Ncam is also strongly reduced
in the ventral neural tube of mutants (Fig. 3N). These data suggest
that ventral progenitor cells are speciﬁed correctly, but that their
differentiation into neurons is severely affected in the mutant. This
includes deﬁciencies in motor neuron differentiation, consistent
with the lack of muscle ﬂexion in the hindlimbs at later stages.
We also assessed effects on the dorsal neural tube. While roof
plate expression of Lmx1a was maintained (Fig. 3F), as described
above, expression of the dorsal interneuron progenitor 1 marker
Atoh1 was strongly reduced or absent in mutant embryos at E10.5
(Fig. 3O). Consistent with this result, Atoh1 mRNA levels are also
reduced, as are mRNA levels of Olig3 (pd 1–3) and Lbx1 (pd 4–6)
(Fig. 3P). These results suggest that dorsal neural progenitor cells
that require BMP signaling for their induction are sensitive to
Geminin loss in mutants. However, critical dorsal signaling ligands
including Gdf7, Wnt1, and Wnt3a are expressed at normal levels,
indicating that the defects may reﬂect neural cell intrinsic
responses rather than loss of key dorsal signaling cues (Fig. 3P).
Together, these results suggest that speciﬁcation of some dorsal
progenitor identities and differentiation of neuronal populations,
particularly ventral motor neurons, is delayed or reduced in the
Geminin deﬁcient embryos.
Fig. 2. Geminin loss causes spinal neural tube defects and axial skeletal malformation. (A) E12.5 mutant (Mox2Cre; Gmnnﬂox/ﬂox) embryos have spinal NTDs. Arrowhead
indicates spinal NTD. (B and C) Hematoxylin/eosin stained transverse section of embryos in (A) (scale bars¼100 mm). (D and E) E14.5 embryos have a kinked spinal neural
tube (arrowhead). (F–H) Dorsal view of E18.5 embryos demonstrating spinal neural tube defects (arrowheads). (I–K) Lateral view of E18.5 embryos. (L–Q) Arrowheads
indicate microphthalmia (L and M), mandible agenesis (N and O), and malformed and curled tail (P and Q) in E18.5 mutant embryos. (R–T) E18.5 embryos stained for ossiﬁed
bone (red) and cartilage (blue). Mutant embryos (S and T) have fused or absent neural arches and vertebral bodies as well as malformed or absent proximal and distal
portions of the ribs.
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To determine if these progenitors were delayed in their
differentiation timing, we also stained E11.5 and E12.5 embryos
with markers of progenitors and differentiated neurons. At E12.5,
mutant embryos had an expanded Ki67-positive ventricular zone
(Fig. S5 B). Consistent with the perdurance of progenitors in
mutant embryos, expression of dorsal and ventral progenitor
markers Atoh1 and Nkx6.1 persisted in mutant embryos at E12.5,
while these markers were absent or weakly expressed in wild-
type embryos (Fig. S5 D,F,H). Ncam and Isl1/2 are markers of
differentiation and instead showed reduced expression in mutants
at E12.5 (Fig. S5 J and K). Together, these results suggest that
Geminin is required for appropriate differentiation of neural
progenitors, as these progenitors persist and show reduced and
delayed differentiation in mutant embryos.
Loss of Geminin in the spinal neural tube results in defective
progenitor speciﬁcation and neurogenesis
To obtain a more comprehensive view of signiﬁcant transcrip-
tional differences between wild-type and mutant (Mox2Cre;
Gmnnﬂox/ﬂox)embryos, we performed microarray analysis on RNA
captured from spinal neural tubes of wild-type and mutant
embryos. Laser capture microdissection was used to collect neural
tube tissue from sections of the trunk between the forelimb and
hindlimb buds at E10.5 using somite-matched mutant and wild-
type littermates. Genes showing signiﬁcantly different expression
between wild-type and mutant neural tube tissue in each of two
independent experiments were deﬁned as described in the Mate-
rials and Methods (Table S4).
Consistent with the immunohistochemistry data, many tran-
scription factors that regulate neural plate patterning and neuro-
nal differentiation showed strongly diminished expression in
mutant neural tube tissue. These included genes whose expression
marks differentiated ventral interneurons and/or motor neurons,
including Hb9, Evx1, Isl1, Isl2, and Lhx5 (Fig. 4A). Expression of
genes that mark dorsal interneuron progenitors including Atoh1
and transcription factors that promote neurogenesis and neural
plate patterning, including Neurog3, Neurod1, Ebf1, Nhlh2, Heyl
and Irx6, was also reduced. We also saw diminished expression of
genes with roles in later neuronal function (e.g. axonal pathﬁnding
proteins, including Robo1/3 and Semaphorins). Consistent with
our prior work, there was not a strong presence of genes involved
in cell proliferation or apoptosis in the list of differentially
expressed genes, supporting our ﬁnding that the rate of cell death
is not different between wild-type and mutant embryos (Table S4).
Analysis of enriched gene ontology (GO) terms using the Metacore
Suite indicated that top networks were involved in neurogenesis,
with other top terms relevant to development/neural develop-
ment (e.g. synaptic transmission) (Fig. 4B). While neither ventral
Shh signaling nor dorsal Wnt signaling components appeared to
be altered by Geminin deﬁciency, several components involved
in mediating dorsal BMP signaling responses were diminished,
Fig. 3. Geminin loss decreases expression of dorsal interneuron progenitor markers and ventral neuronal markers. (A–C) Transverse sections of E10.5 spinal neural tube in wt
and mutant (Mox2Cre; Gmnnﬂox/ﬂox) embryos show no difference in proliferative markers. For (C), pH3þ cells/section were quantitated for 3 sections each from the caudal
neural tubes of 6 mutant and 4 wild-type sibling control embryos (18 and 12 sections, respectively); data is expressed as pH3þ cells/section þ/std. dev. (D) Activated/
phosphorylated Caspase3 (pCaspase3) shows very few apoptotic cells in wt and mutant. (E–O) Immunohistochemistry for regionally restricted markers of speciﬁc cell types
in the neural tube. Embryos analyzed for immunohistochemistry (n¼7). (P) qRT-PCR to detect altered expression of regionally restricted genes in spinal tissue (tissue dorsal
of the dorsal aorta was dissected from the forelimb to the last full somite). Fold difference comparison between mutant and wild-type tissue shows decreased expression of
dorsal interneuron progenitor genes (Lbx1, Atoh1, and Olig3), but not dorsal signaling molecules in the mutant; data is expressed as fold differenceþstd. dev. Scale
bars¼100 mm.
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including Smad1, Smad7, Rgmb, and Bmpr1b. Mutant neural tube
tissue also had diminished expression of some genes whose loss
results in NTDs in mouse models, including transcription factors
and chromatin regulatory activities (e.g. Nap1l2, Zic5, Med12),
suggesting that loss of these regulators might contribute to the
failure to close the neural tube here.
There were substantially fewer genes with increased expres-
sion in the mutant neural tube (Table S4). This gene set was
enriched for genes involved in nucleosome and chromatin assem-
bly, including histone genes, and genes that are expressed and
function in neural crest (Cyp26b1, Phox2b, Dlx6) and epithelia
(Dsp, Npnt) (Fig. 4C and D). These may also reﬂect a delay in other
events that occur in the neural tube, such as delamination and
migration of speciﬁc neural crest populations. Together, these
ﬁndings support a requirement for Geminin in promoting the
expression of other transcriptional and chromatin regulatory
activities required for neurogenesis and neural plate patterning.
Mutant embryos have neural crest and axial skeleton defects
Since Mox2-Cre depletes Geminin function in paraxial tissues
as well as in the neural tube, and later embryos showed deﬁcien-
cies in the axial skeleton, we also assessed gene expression
changes resulting from Geminin loss by E10.5 in paraxial tissues.
We performed laser capture microdissection of paraxial tissues
(Fig. S1) through the same trunk region from which neural tissue
was captured and compared RNA from somite-matched wild-type
and mutant siblings by microarray analysis in two independent
experiments, as described in Materials and methods.
Genes with decreased expression in mutant paraxial tissue
included many markers of neural crest (Foxd3, Sox9) and of
mesenchymal tissue that contributes to paraxial mesoderm deri-
vatives including dermomyotome (Pax7), myotome (Myog, Mylpf),
and sclerotome (Pax1/Pax9) (Fig. 5A; Table S5). Consistent with
this, the gene set with decreased expression in mutant paraxial
tissues was strongly associated with GO terms related to muscle
development (Fig. 5C).
Both neural crest migration and somite segmentation into
dermomyotome, myotome and sclerotome to form the muscula-
ture and axial skeleton depend upon de-epithelialization. By
contrast with decreased expression of genes associated with
neural crest cells (NCC) and mesodermal fate acquisition, genes
with increased expression in mutant trunk paraxial tissue
included many genes with roles in epithelial adhesion (Fig. 5B;
Table S5). Most notably there was increased expression of genes
involved in cell adhesion, including tight junctions (Cldn4 and 27)
and desmosomes (Dsg2 and Dsp). Multiple keratins (Krt8/18/19)
were also overexpressed. In addition to genes that function
directly in cell adhesion, the transcription factor Grhl2 is over-
expressed in mutant paraxial tissue. Grhl2 inhibits epithelial to
mesenchymal transitions and its mutation has previously been
shown to cause NTDs. Epcam and Dsp expression decreases in
Grhl2 mutant mice, while increasing in our model, potentially
through increased Grhl2 (Pyrgaki et al., 2011). Consistent with
these examples, top GO terms were associated with cell adhesion
and cell–cell junctions (Fig. 5D).
Given that neural crest-associated gene expression decreased in
mutant paraxial tissue, we also evaluated the presence of differ-
entiated NCCs in day E10.5 embryos by using neuroﬁlament stain-
ing. In the rostral region of the spinal neural tube, NCCs appear to
migrate and differentiate appropriately. However, caudally we
observed a lack of differentiated NCCs as visualized by neuroﬁla-
ment staining, indicating either a defect in migration or differentia-
tion (Fig. 5E and F). Together, these ﬁndings suggest that loss
of Geminin in the Mox2-Cre model also delays or blocks differentia-
tion of paraxial structures, consistent with the later ﬁndings of
perturbed axial skeletal development in mutant embryos (Fig. 2S
and T).
Fig. 4. Geminin loss causes diminished expression of transcription factors that control neurogenesis and neural tube patterning and of NTD-related genes. Genes that
showed signiﬁcantly decreased (A) or increased (C) expression levels in mutant (Mox2Cre; Gmnnﬂox/ﬂox) versus wt embryos were deﬁned by microarray analysis of laser
capture microdissected trunk neural tube. (B and D) Enriched gene ontology (GO) terms for these data sets were deﬁned using the MetaCore Suite/GeneGO software.
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Geminin is required in neuroepithelium from embryonic day
8.5 through 10.5
Since Mox2-Cre is broadly expressed in cells that give rise to the
neural tube and axial skeleton, this model did not enable us to deﬁne
temporal or spatial requirements for Geminin activity for neural tube
closure, patterning and differentiation, or for axial skeletal develop-
ment. To address this question, we next crossed the Geminin ﬂoxed
allele to several temporally- and tissue-restricted drivers. We began by
using the Dermo1-Cre line where Cre is expressed in mesenchymal
cells but not in neural tissues from approximately E10 (Fig. S6 A and
A0) (Yokoyama et al., 2009). Dermo1Cre; Gmnnﬂox/ﬂox animals were
viable and fertile and embryos with this genotype had neither spinal
neural tube defects nor axial skeleton defects (data not shown). These
data indicate that Geminin is not required after E10.5 in paraxial
mesenchyme for later aspects of formation of the axial skeleton, but
do not preclude roles for Geminin in mesodermal derivatives prior to
E9.5–10.5, when expression of Dermo1-Cre begins. We also found that
NestinCre; Gmnnﬂox/ﬂox mice, where Geminin was excised predomi-
nantly in the ventral spinal neural tube from E9.5 to E10.5 (Fig. S6 B
and B0–E and E0), were viable and fertile with no apparent alterations
in nervous system development, consistent with a prior study (Schultz
et al., 2011). These data suggest that Geminin activity is likely to be
dispensable for embryonic patterning in both neural and axial
mesenchymal tissues after E10–E10.5.
To address whether neural deﬁciencies observed in our Mox2-
Cre model reﬂected a neural tissue autonomous defect, we next
asked whether conditional deletion of Geminin by two Cre lines
that drive spatially restricted expression in the nervous system at
earlier developmental time points than Nestin-Cre would result in
NTDs. To determine if Geminin was required speciﬁcally in the
spinal neural tube or if Geminin was also required in the cranial
neural tube, we used Wnt1-Cre to excise Geminin in the dorsal
midbrain beginning at E8.5. Expression of Wnt1-Cre is restricted
to the brain prior to E9.5 and progresses caudally such that
expression also encompasses the dorsal spinal neural tube by
E10.5 (Stottmann and Klingensmith, 2011). Wnt1-Cre mutant
embryos (Wnt1Cre; Gmnnﬂox/ﬂox) have small midbrains at E10.5,
which results in complete penetrance of exencephaly in later stage
embryos (Fig. 6A–D). However, the later loss of Geminin activity in
Fig. 5. Geminin loss in paraxial tissue results in decreased expression of muscle/mesenchymal genes and increased expression of cell adhesion related and intermediate
ﬁlament genes. Genes with signiﬁcantly decreased (A) or increased (B) expression in mutant (Mox2Cre; Gmnnﬂox/ﬂox) versus wt embryos were deﬁned by microarray analysis
of trunk paraxial tissue. (C,D) Top GO terms were deﬁned using Metacore Suite/GeneGo for these data sets. (E and F) Neuroﬁlament immunostaining of wt (E) or mutant
(F) embryos. (E0 and F0) boxed regions from (E and F). For several somites, white arrows highlight neuroﬁlament staining and black arrowheads denote somite boundaries. In
the mutant, staining for neural crest is normal in the rostral trunk, but differentiated neural crest is absent in the caudal region of the trunk.
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the dorsal spinal neural tube (compared to the Mox2-Cre driver)
resulted in embryos with normal caudal development with
neither spinal NTDs nor axial skeleton defects (Fig. 6A–D).
We also used a line carrying a Pax3-Cre transgene, which is
expressed in the dorsal half of the neural tube and neural crest, but
not in the somites, beginning as early as E8.5 (Stottmann and
Klingensmith, 2011). Pax3-Cre is expressed only in the caudal two-
thirds of the embryo, with expression beginning near the level of the
otic vesicle (Jarad and Miner, 2009; Stottmann and Klingensmith,
2011). Consistent with the expression proﬁle of the Pax3-Cre trans-
gene, by E9.5 Geminin protein is not detectable in the spinal neural
tube of mutant embryos (Pax3Cre; Gmnnﬂox/ﬂox), but remains in non-
neural paraxial cells (Fig. S6F and G). At E10.5, mutant embryos
showed normal rostral spinal neural tube and somites, but the
dorsal neural tube appeared to be sunken in caudal regions of the
embryo. By E12.5, mutants exhibited severe spinal neural tube defects
(Fig. 6E and F). We dissected and sectioned E12.5 embryos and upon
gross examination and hematoxylin/eosin staining, it was evident that
they lacked a caudal neural tube from the same rostral–caudal levels
where the Pax3-Cre transgene is expressed (Fig. 6G and H). This
resulted in E18.5 mutant embryos that lacked a neural tube and also
had axial skeleton defects, speciﬁcally abnormal or missing ribs and
fused or absent vertebrae (Fig. 6I–M). However, we never saw micro-
phthalmia or mandible loss in Pax3-Cre mutant embryos, consistent
with lack of rostral Cre expression from the Pax3-Cre transgene.
We examined the neural tubes of Pax3-Cre mutant embryos
(Pax3Cre; Gmnnﬂox/ﬂox) at E10.5 and found that, even within litters,
there was variable morphology. Within a litter, we observed
mutant embryos with grossly normal neural tubes (Fig. 7, mut1)
to mutants that lacked caudal neural tubes (Fig. 7, mut2). The most
severely affected mutant embryos (mut2) had strongly reduced
Ki67 and lacked expression of all progenitor and differentiation
Fig. 6. Wnt1-Cre and Pax3-Cre mediated Geminin deletion cause distinct neural tube defects. (A and B) Lateral view of E10.5 wt and mutant (Wnt1Cre; Gmnnﬂox/ﬂox) embryos.
Mutant embryo (B) has a reduced midbrain (region between arrowheads) and diminished pharyngeal arches (arrowhead). (C and D) At E15.5, Wnt1-Cre mutant embryos
exhibit exencephaly and lack mandibles. (E and F) Dorsal view of wt and mutant (Pax3Cre; Gmnnﬂox/ﬂox) embryos at E12.5 shows degeneration of the spinal neural tube in
mutant embryos. Arrowhead in F indicates the caudal extent of the neural tube. (G and H) Hematoxylin/eosin stained sections taken at the rostral–caudal levels indicated in
(E and F). Lateral (I and J) and dorsal (K and L) views of E18.5 mutant (Pax3Cre; Gmnnﬂox/ﬂox) embryos show a loss of the spinal neural tube. Arrowhead in L indicates the caudal
extent of the neural tube. (M) Skeletal and cartilage preparations of E18.5 mutant (Pax3Cre; Gmnnﬂox/ﬂox) embryos. Embryo has a compressed torso with malformed ribs and
fused or absent vertebrae. Scale bars¼100 mm.
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Fig. 7. Pax3-Cre mediated Geminin deletion decreases expression of dorsal interneuron progenitor markers and ventral neuronal markers. Awt and twomutant (Pax3Cre; Gmnnﬂox/ﬂox)
E10.5 littermate embryos (mut1,2) are shown to present the range of phenotypes observed at this time. mut2 lacks dorsal and ventral progenitor marker expression, consistent with
the degenerated neural tube structure. In comparisons of wt and mut1, (A–D) transverse sections of E10.5 spinal neural tube show no difference in proliferative markers Ki67 and pH3.
(E–H) Mutant embryos have diminished expression of the dorsal progenitor marker Atoh1, but not the ventral progenitor marker Nkx2.2. (I–N) Differentiation markers Hb9, Isl1, and,
Ncam are decreased in mutant embryos. Arrowheads indicate the notochord for mut2 images. Embryos analyzed for immunohistochemistry (n¼5). Scale bar¼100 mm.
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markers, consistent with degeneration of the neural tube at this
time (Fig. 7). The proliferative markers Ki67 and pH3 showed no
differences between wt and mutant embryos with grossly normal
neural tube structures (mut1) at E10.5 (Fig. 7A–D). However, when
we examined transcription factor expression in the spinal neural
tube, expression of the dorsal neural tube marker Atoh1 was lost
in mutants (Fig. 7E and F), similar to what we found in Mox2-Cre
mutant embryos. Also, similar to Mox2-Cre mutant embryos,
Nkx2.2 expression was not affected in mut1 (Fig. 7G and H), while
Hb9, Isl1, and Ncam expression were greatly reduced in all Pax3-
Cre mutant embryos, indicating a defect in motor neuron differ-
entiation (Fig. 7I N). Therefore, these data suggest a neural tissue
autonomous requirement for Geminin in the neural plate during
the time window when neural plate patterning and neural tube
closure occur (E8.5-E10.5).
Together, these models demonstrate a strict requirement for
Geminin in differentiating neuroepithelium. Lack of Geminin in
the neural tube results in either exencephaly or caudal NTDs
depending on the rostral–caudal region where Geminin is deleted.
In addition, these data demonstrate a critical time window when
Geminin is required tissue autonomously in the neural tube
between E8.5 and E10.5. Marker analysis and comprehensive
comparisons of gene expression changes resulting from Geminin
deﬁciency suggest that failure to activate programs of gene
expression that drive dorsal neural speciﬁcation and neuronal
differentiation may contribute to the neural tube defects that
occur in these embryos.
Discussion
Here we have identiﬁed a critical role for Geminin during
neural tube formation. We used a ﬂoxed Geminin allele combined
with various Cre drivers to deﬁne the temporal and spatial
requirements for Geminin during neurulation. Mox2-Cre mutant
embryos have completely penetrant caudal NTDs. In these
embryos, ventral interneuron progenitors are speciﬁed, but differ-
entiation is impaired, while dorsal interneuron progenitors are not
speciﬁed or are drastically reduced in number. Similar results were
obtained upon using a Pax3-Cre driver, which excised Geminin
speciﬁcally in caudal neural tissues from E8.5, while deletion of
Geminin from E8.5 in the midbrain using Wnt1-Cre instead caused
exencephaly. Wnt1-Cre mediated deletion of Geminin in the spinal
neural tube (from E10.5) did not result in caudal NTDs. Excision of
Geminin in neural tissues from E10 to E10.5 with Nestin-Cre or
in paraxial mesenchyme using Dermo1-Cre resulted in normal
nervous system development and embryos developed into viable,
fertile adults. Together, these data suggest that Geminin activity is
required in neural plate tissue during the time window when
speciﬁcation of interneuron progenitors and other aspects of
neural plate patterning, initiation of neuronal differentiation, and
neural tube closure occur.
Many genes, when mutated in the mouse, can result in NTDs
(Harris and Juriloff, 2010, 2007). These genes can be grouped into
several categories according to the cellular processes affected.
These include defects in anterior–posterior patterning of the
embryo, in the signaling systems that drive dorsal–ventral pat-
terning of the neural tube, and in multiple other processes
required for proper neural development, including planar cell
polarity/cell orientation, formation of neural hinge points, cell
proliferation, apoptosis, and differentiation (Copp and Greene,
2010; Pyrgaki and Niswander, 2013). NTDs caused by defects in
anterior–posterior patterning are typically secondary sequelae of
mispatterning the anterior–posterior axis, resulting in defects that
present by E8.5–E9.5 and often result in lethality by E9.5 (Harris
and Juriloff, 2007). Mox2-Cre and Pax3-Cre mutant embryos do
not show overt defects until E10.5, survive until birth, and
anterior–posterior patterning of the body axis is intact, suggesting
a different etiology for the NTDs in these models.
NTDs can also be caused by mutation of genes in the planar cell
polarity (PCP) pathway (Juriloff and Harris, 2012; Wallingford et
al., 2013). These genes affect cell shape/polarity and movements
that drive convergent extension during gastrulation to control
lengthening of the A–P body axis. PCP pathway genes are also
required for apical constriction during hinge point formation in
the neural tube, a necessary step of neural tube closure, and
mutation of PCP pathway genes causes the most severe type of
NTD, craniorachichisis, where both the rostral and caudal aspects
of the NT fail to close (Copp et al., 2013). Hinge point formation
appears to be normal in Mox2-Cre mutant embryos and we never
observed craniorachichisis in our model, nor did we see PCP
pathway genes differentially expressed in mutant neural tubes in
our array analysis, suggesting this is also not the basis of the NTD
seen upon Geminin deﬁciency.
Changes in either cell proliferation or apoptosis can also result
in neural tube defects (Copp and Greene, 2010; Pyrgaki and
Niswander, 2013). Geminin is one of several activities that regulate
re-licensing of DNA origins of replication through inhibitory
binding to Cdt1, to prevent re-replication of the genome within a
cell cycle. Therefore, we assayed for changes in proliferation and
apoptosis in Geminin deﬁcient embryos. We did not see changes in
the mitotic marker pH3, nor did we see changes in activated
Caspase3, an apoptotic marker. We cannot rule out the possibility
that loss of Geminin caused proliferative or apoptotic changes that
we were unable to detect. However, we did not detect changes in
these pathways in our microarrays and could not visually distin-
guish wild-type from mutant embryos prior to the time of neural
tube closure, suggesting that these effects, if present, are not a
major contributor to the phenotype. Other mechanisms for inhi-
biting Cdt1 activity by proteolysis may compensate for the loss of
Geminin here, as is seen in other normal cell contexts where
Geminin loss does not result in altered cell proliferation (Nishitani
et al., 2006; Zhu and Depamphilis, 2009).
NTDs can also be caused through perturbation of differentiation
in the neural tube (Copp and Greene, 2010). Investigation of neural
tube differentiation in mutant (Mox2Cre; Gmnnﬂox/ﬂox ) embryos
identiﬁed reduced expression of neurogenic transcription factors
that function in discrete dorsal–ventral cell domains. Dorsal–ventral
patterning of the neural tube results from integration of growth
factor signals, particularly ventral Shh and dorsal Bmp and Wnt
signals. Disruption of these signaling pathways can dorsalize
(for Shh) or ventralize (for Bmp/Wnt) the neural tube, leading to
NTDs (Alvarez-Medina et al., 2008; Chiang et al., 1996; Le Dréau and
Martí, 2013; Lee and Jessell, 1999). We did not observe dorsalization
or ventralization of the neural tube and our microarrays did not
indicate changes in Wnt or Shh signaling pathway components or
BMP growth factors. However, we observed decreased expression of
several components that mediate the dorsal BMP growth factor
response (decreased expression of Smad1, Smad7, and Bmpr1b).
Furthermore, genes whose expression was strongly affected in the
mutant neural tube are neurogenic transcription factors required for
speciﬁcation, patterning and differentiation of the neural tube,
including Neurod1, Neurog3, Nhlh2, Atoh1, Hb9, and Isl1. This is in
agreement with our immunohistochemistry results, demonstrating
decreased expression of Atoh1, Hb9, and Isl1. Atoh1 controls speci-
ﬁcation of dorsal interneuron progenitors (pd1) (Helms and Johnson,
1998) and is among the most strongly downregulated genes in
Geminin mutant neural tubes. During neural cell speciﬁcation from
embryonic stem cells in vitro, we previously observed that Geminin
could directly bind and/or promote increased histone acetylation at
the promoters of several of these genes (Atoh1, Neurod1, Zic5),
promoting their expression (Yellajoshyula et al., 2011). These ﬁndings
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suggest that some effects of Geminin in promoting expression of
regulators of neural speciﬁcation and neurogenesis may be direct.
Geminin loss in the mutant also resulted in decreased expression of
several transcription factors or chromatin regulators whose loss in
other mouse models results in NTDs, including Nap1l2, Med12, and
Zic5 (Attia et al., 2007; Inoue et al., 2004; Rocha et al., 2010; Rogner
et al., 2000).
Geminin has essential functions in cell fate speciﬁcation
mediated through its interactions with the Polycomb repressor
and SWI/SNF chromatin remodeling complexes (PRC and SWI/SNF)
and with Hox and Six family homeodomain transcription factors
(Del Bene et al., 2004; Luo et al., 2004; Seo et al., 2005). Previously,
we demonstrated that Geminin has a role in regulating the
epigenetic status, expression, or activity of critical transcription
factors during primary neurogenesis in Xenopus and also during
in vitro mouse ES cell differentiation towards neuroectoderm (Lim
et al., 2011; Seo et al., 2005; Yellajoshyula et al., 2012, 2011).
However, analyzing Geminin's in vivo function in mammals was
hampered due to the preimplantation lethality of Geminin null
embryos (Gonzalez et al., 2006).
Here, we have demonstrated a functional requirement for
Geminin during neuroepithelium formation and neural tube
patterning in vivo between E8.5 and E10.5. Loss of Geminin altered
expression of transcriptional and epigenetic regulators that are
important for neural tube closure. Mutation of chromatin regula-
tors or changes in chromatin modiﬁcations due to environmental
factors (low dietary folic acid intake or gestational diabetes) can
also cause NTDs (Copp and Greene, 2010; Pinney and Simmons,
2012; Salbaum and Kappen, 2010). Together, our ﬁndings indicate
that Geminin is essential during neural tube formation for speci-
ﬁcation and differentiation of neural tube progenitors, and suggest
that this may occur through regulation of transcription or func-
tional interactions with chromatin regulators to control the
epigenetic status and expression of genes that drive neurogenesis
and neural plate patterning.
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